TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:02
Adagio Medical Holdings Inc. ( ADGM ) https://adagiomedical.com
1.06USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
ADGM
0.00%
SPY
32.66%
ADGM
0.00%
SPY
108.59%
ADGM
0.00%
SPY
302.52%
ADGM
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
15.41
1.27
1.14
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
36.14
31.44
0.20
-62.69
0.00
-0.08
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-3352.27
-213.64
-2835.61
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-155.91
-30.66
0.00
Other Earnings and Cash Flow Stats:
Adagio Medical Holdings Inc. ( ADGM ) Net Income TTM ($MM) is 0.43
Adagio Medical Holdings Inc. ( ADGM ) Operating Income TTM ($MM) is -14.44
Adagio Medical Holdings Inc. ( ADGM ) Owners' Earnings Annual ($MM) is 0.00
Adagio Medical Holdings Inc. ( ADGM ) Current Price to Owners' Earnings ratio is 0.00
Adagio Medical Holdings Inc. ( ADGM ) EBITDA TTM ($MM) is -13.67
Adagio Medical Holdings Inc. ( ADGM ) EBITDA Margin is -2835.61%
Capital Allocation:
Adagio Medical Holdings Inc. ( ADGM ) has paid 0.00 dividends per share and bought back -7.106805 million shares in the past 12 months
Adagio Medical Holdings Inc. ( ADGM ) has reduced its debt by 16.043 million USD in the last 12 months
Capital Structure:
Adagio Medical Holdings Inc. ( ADGM ) Interest-bearing Debt ($MM) as of last quarter is 14
Adagio Medical Holdings Inc. ( ADGM ) Annual Working Capital Investments ($MM) are -11
Adagio Medical Holdings Inc. ( ADGM ) Book Value ($MM) as of last quarter is 76
Adagio Medical Holdings Inc. ( ADGM ) Debt/Capital as of last quarter is 18%
Other Balance Sheet Stats:
Adagio Medical Holdings Inc. ( ADGM ) has 28 million in cash on hand as of last quarter
Adagio Medical Holdings Inc. ( ADGM ) has 7 million of liabilities due within 12 months, and long term debt 61 as of last quarter
Adagio Medical Holdings Inc. ( ADGM ) has 14 common shares outstanding as of last quarter
Adagio Medical Holdings Inc. ( ADGM ) has 0 million USD of preferred stock value
Academic Scores:
Adagio Medical Holdings Inc. ( ADGM ) Altman Z-Score is -0.06 as of last quarter
Adagio Medical Holdings Inc. ( ADGM ) Piotroski Score is 4.00 as of last quarter
Corporate Governance:
Adagio Medical Holdings Inc. ( ADGM ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of Adagio Medical Holdings Inc. ( ADGM ) for the amount of $ on
0.33% of Adagio Medical Holdings Inc. ( ADGM ) is held by insiders, and 27.68% is held by institutions
Adagio Medical Holdings Inc. ( ADGM ) went public on 2024-08-01
Other Adagio Medical Holdings Inc. ( ADGM ) financial metrics:
FCF:-16.42
Unlevered Free Cash Flow:0.00
EPS:0.99
Operating Margin:-3352.27
Gross Profit Margin:-213.64
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:18.84
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Adagio Medical Holdings Inc. ( ADGM ) :
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company was founded in 2011 and is headquartered in Laguna Hills, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.